• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PredictAAT:在 Alpha 1 抗胰蛋白酶缺乏症诊断中考虑炎症因素。

PredictAAT: Accounting for Inflammation in the Diagnosis of Alpha 1 Antitrypsin Deficiency.

机构信息

Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, The Lung Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

COPD. 2020 Dec;17(6):619-622. doi: 10.1080/15412555.2020.1812055. Epub 2020 Aug 30.

DOI:10.1080/15412555.2020.1812055
PMID:32862719
Abstract

Alpha 1 antitrypsin deficiency (AATD) is a rarely diagnosed hereditary condition characterized by low alpha 1 antitrypsin (AAT) levels, which can lead to early-onset emphysema due to accelerated degradation of lung tissue. Similar to C-reactive protein (CRP), AAT is an acute phase reactant, meaning that blood levels rise in response to inflammation, injury or infection. Testing AAT levels is essential in the diagnosis of AATD; however, the presence of inflammation at the time of AATD testing can provide a false 'normal' level reading of the patient's baseline AAT levels. Researchers from a US-wide screening program for AATD found that a large number of individuals with AATD variants (particularly with the PI*MZ genotype) presented with elevated CRP levels (≥5 mg/L), suggesting the presence of inflammation. Using a series of calculations, the relationship between AAT and CRP levels was characterized and found to be genotype specific. We have developed a publicly available, easy-to-use online calculator (PredictAAT) that enables the instant calculation of predicted baseline AAT levels in patients exhibiting elevated CRP levels that accounts for specific AATD genotype. There is a need to raise awareness of the importance of simultaneous determination of AAT and CRP levels to aid the accurate diagnosis of patients with AATD. The PredictAAT calculator is therefore a valuable tool for physicians to enhance early disease diagnosis and individualize treatment.

摘要

α1-抗胰蛋白酶缺乏症(AATD)是一种罕见的遗传性疾病,其特征是α1-抗胰蛋白酶(AAT)水平降低,这可能导致肺组织加速降解的早发性肺气肿。与 C 反应蛋白(CRP)类似,AAT 是一种急性时相反应物,这意味着在炎症、损伤或感染时血液水平会升高。检测 AAT 水平对 AATD 的诊断至关重要;然而,在进行 AATD 检测时存在炎症会导致患者基础 AAT 水平的假“正常”读数。来自美国一项 AATD 筛查计划的研究人员发现,大量 AAT 变异体(尤其是 PI*MZ 基因型)患者的 CRP 水平升高(≥5mg/L),这表明存在炎症。通过一系列计算,研究人员描述了 AAT 和 CRP 水平之间的关系,并发现其具有基因型特异性。我们开发了一个易于使用的在线计算器(PredictAAT),该计算器可以即时计算出 CRP 水平升高的患者的预测基础 AAT 水平,同时考虑了特定的 AATD 基因型。因此,需要提高对同时测定 AAT 和 CRP 水平以帮助准确诊断 AATD 患者的重要性的认识。PredictAAT 计算器是医生增强早期疾病诊断和个体化治疗的有价值的工具。

相似文献

1
PredictAAT: Accounting for Inflammation in the Diagnosis of Alpha 1 Antitrypsin Deficiency.PredictAAT:在 Alpha 1 抗胰蛋白酶缺乏症诊断中考虑炎症因素。
COPD. 2020 Dec;17(6):619-622. doi: 10.1080/15412555.2020.1812055. Epub 2020 Aug 30.
2
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants.C 反应蛋白和 α1-抗胰蛋白酶:水平与基因变异的关系。
Transl Res. 2011 Jun;157(6):332-8. doi: 10.1016/j.trsl.2010.12.014. Epub 2011 Jan 27.
3
Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?与基于α1抗胰蛋白酶(AAT)浓度的筛查方法相比,综合实验室算法在检测慢性阻塞性肺疾病(COPD)患者α1抗胰蛋白酶缺乏症方面是否更有效?
Biochem Med (Zagreb). 2014;24(2):293-8. doi: 10.11613/BM.2014.032. Epub 2014 Jun 15.
4
The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort.全国筛查队列中炎症对α1抗胰蛋白酶水平的影响
COPD. 2018 Feb;15(1):10-16. doi: 10.1080/15412555.2017.1401600. Epub 2018 Jan 30.
5
Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.α-1抗胰蛋白酶缺乏症慢性阻塞性肺疾病患者的主动病例筛查及静脉注射α-1抗胰蛋白酶治疗的指征:最新进展
Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12.
6
The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.初级保健提供者在α-1抗胰蛋白酶缺乏症检测中的重要作用。
Postgrad Med. 2017 Nov;129(8):889-895. doi: 10.1080/00325481.2017.1381539. Epub 2017 Oct 5.
7
Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.慢性阻塞性肺疾病患者的α-1 抗胰蛋白酶缺乏症:一项横断面研究。
Arch Bronconeumol. 2015 Nov;51(11):539-43. doi: 10.1016/j.arbres.2015.01.008. Epub 2015 Mar 21.
8
Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.针对 PI*MZ 基因型个体的α-1 抗胰蛋白酶(AAT)增强疗法:针对一个工作假设的赞成/反对辩论。
BMC Pulm Med. 2021 Mar 23;21(1):99. doi: 10.1186/s12890-021-01466-x.
9
Alpha-1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):629-33. doi: 10.1016/j.bpg.2010.08.006.
10
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.土耳其慢性阻塞性肺疾病、支气管扩张或哮喘患者的α-1 抗胰蛋白酶缺乏症筛查研究。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 28;18:2785-2794. doi: 10.2147/COPD.S425835. eCollection 2023.

引用本文的文献

1
Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency.增进对与α1抗胰蛋白酶缺乏症相关的肺部病变的理解和治疗。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251318841. doi: 10.1177/17534666251318841.
2
Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.2015 年至 2019 年参考实验室中 α-1 抗胰蛋白酶缺乏症诊断趋势。
Int J Chron Obstruct Pulmon Dis. 2020 Oct 7;15:2421-2431. doi: 10.2147/COPD.S269641. eCollection 2020.